Mota Roberto I, Morgan Samuel E, Bahnson Edward M
Department of Surgery, Division of Vascular Surgery; University of North Carolina at Chapel Hill, NC 27599.
Center for Nanotechnology in Drug Delivery; University of North Carolina at Chapel Hill, NC 27599.
Curr Pathobiol Rep. 2020 Mar;8(1):1-14. doi: 10.1007/s40139-020-00205-x. Epub 2020 Jan 27.
Diabetes is a common and prevalent medical condition as it affects many lives around the globe. Specifically, type-2 Diabetes (T2D) is characterized by chronic systemic inflammation alongside hyperglycemia and insulin resistance in the body, which can result in atherosclerotic legion formation in the arteries and thus progression of related conditions called diabetic vasculopathies. T2D patients are especially at risk for vascular injury; adjunct in many of these patients heir cholesterol and triglyceride levels reach dangerously high levels and accumulate in the lumen of their vascular system.
Microvascular and macrovascular vasculopathies as complications of diabetes can accentuate the onset of organ illnesses, thus it is imperative that research efforts help identify more effective methods for prevention and diagnosis of early vascular injuries. Current research into vasculopathy identification/treatment will aid in the amelioration of diabetes-related symptoms and thus reduce the large number of deaths that this disease accounts annually.
This review aims to showcase the evolution and effects of diabetic vasculopathy from development to clinical disease as macrovascular and microvascular complications with a concerted reference to sex-specific disease progression as well.
糖尿病是一种常见且普遍的病症,影响着全球众多人的生活。具体而言,2型糖尿病(T2D)的特征是全身慢性炎症,同时伴有高血糖和体内胰岛素抵抗,这会导致动脉粥样硬化斑块形成,进而引发称为糖尿病血管病变的相关病症进展。T2D患者尤其面临血管损伤风险;许多此类患者的胆固醇和甘油三酯水平会升至危险的高水平,并在其血管系统管腔中积聚。
作为糖尿病并发症的微血管和大血管血管病变会加剧器官疾病的发作,因此,研究工作必须有助于确定更有效的早期血管损伤预防和诊断方法。目前对血管病变识别/治疗的研究将有助于改善糖尿病相关症状,从而减少该疾病每年造成的大量死亡。
本综述旨在展示糖尿病血管病变从发展到临床疾病的演变及影响,包括大血管和微血管并发症,并同时协调参考性别特异性疾病进展情况。